aluates Reports

$ 0.0

Automative

Global Post herpetic Neuralgia Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: July 2025

Report Code: QYRE-Auto-29M2276

Global Post herpetic Neuralgia Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Post herpetic Neuralgia Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-29M2276

Report

July 2025

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

TEVA

Mylan NV

Hengrui Medicine

Post herpetic Neuralgia Treatment Market Size

In 2024, the global market size of Post herpetic Neuralgia Treatment was estimated to be worth US$ 1714 million and is forecast to reach approximately US$ 2247 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.

Post herpetic Neuralgia Treatment Market

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.

In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.

The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Post herpetic Neuralgia Treatment Market Report

Report Metric	Details
Report Name	Post herpetic Neuralgia Treatment Market
CAGR	4.0%
Segment by Type	Anticonvulsants Skin Patch Other Segment by Distribution Channel Hospital Pharmacies Online Pharmacies Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Post herpetic Neuralgia Treatment in global and regional level.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post herpetic Neuralgia Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 8: Europe by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Distribution Channel and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the market share of major companies in Post herpetic Neuralgia Treatment Market?

Ans: Global top five manufacturers hold a share about 80%.

What is the Post herpetic Neuralgia Treatment Market share by type?

Ans: In terms of product, Anticonvulsants is the largest segment, with a share over 80%.

Who are the main players in the Post herpetic Neuralgia Treatment Market report?

Ans: The main players in the Post herpetic Neuralgia Treatment Market are Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine

What are the Type segmentation covered in the Post herpetic Neuralgia Treatment Market report?

Ans: The Types covered in the Post herpetic Neuralgia Treatment Market report are Anticonvulsants, Skin Patch, Other, Segment by Distribution Channel, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

1 Study Coverage

1.1 Post herpetic Neuralgia Treatment Product Introduction

1.2 Market by Type

1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Anticonvulsants

1.2.3 Skin Patch

1.2.4 Other

1.3 Market by Distribution Channel

1.3.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Distribution Channel (2020 VS 2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Post herpetic Neuralgia Treatment Market Size Estimates and Forecasts

2.2 Post herpetic Neuralgia Treatment Market Size by Region: 2024 Versus 2031

2.2.1 Global Post herpetic Neuralgia Treatment Revenue by Region: 2020-2025

2.2.2 Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031)

2.2.3 Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2031)

3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Distribution Channel

3.2.1 Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2031)

3.2.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2031)

3.3 by Type and by Distribution Channel Crossing Analysis

3.3.1 Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel

3.3.2 Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel

3.3.3 Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel

4 Global Post herpetic Neuralgia Treatment by Company

4.1 Global Post herpetic Neuralgia Treatment Revenue by Company (2020-2025)

4.2 Global Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key Post herpetic Neuralgia Treatment Companies around the World: Ranking by Revenue

4.3.2 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global Post herpetic Neuralgia Treatment Companies Headquarters & Product Type

4.4.1 Global Post herpetic Neuralgia Treatment Companies Headquarters

4.4.2 Date of International Companies Enter into Post herpetic Neuralgia Treatment Market

4.4.3 Global Post herpetic Neuralgia Treatment Companies Product & Service

4.4.4 Anticonvulsants Revenue Market Share of Post herpetic Neuralgia Treatment by Company

4.4.5 Skin Patch Revenue Market Share of Post herpetic Neuralgia Treatment by Company

4.4.6 Other Revenue Market Share of Post herpetic Neuralgia Treatment by Company

4.5 Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Pfizer

5.1.1 Pfizer Corporation Information

5.1.2 Pfizer Description, Business Overview

5.1.3 Pfizer Post herpetic Neuralgia Treatment Products Offered

5.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.1.5 Pfizer Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.1.6 Pfizer Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.1.7 Pfizer Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.1.8 Pfizer Recent Developments

5.2 Arbor Pharma

5.2.1 Arbor Pharma Corporation Information

5.2.2 Arbor Pharma Description, Business Overview

5.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Products Offered

5.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.2.5 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.2.6 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.2.7 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.2.8 Arbor Pharma Recent Developments

5.3 Assertio Therapeutics

5.3.1 Assertio Therapeutics Corporation Information

5.3.2 Assertio Therapeutics Description, Business Overview

5.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Products Offered

5.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.3.5 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.3.6 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.3.7 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.3.8 Assertio Therapeutics Recent Developments

5.4 Endo Pharma

5.4.1 Endo Pharma Corporation Information

5.4.2 Endo Pharma Description, Business Overview

5.4.3 Endo Pharma Post herpetic Neuralgia Treatment Products Offered

5.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.4.5 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.4.6 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.4.7 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.4.8 Endo Pharma Recent Developments

5.5 Teikoku Pharma

5.5.1 Teikoku Pharma Corporation Information

5.5.2 Teikoku Pharma Description, Business Overview

5.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Products Offered

5.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.5.5 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.5.6 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.5.7 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.5.8 Teikoku Pharma Recent Developments

5.6 Teva

5.6.1 Teva Corporation Information

5.6.2 Teva Description, Business Overview

5.6.3 Teva Post herpetic Neuralgia Treatment Products Offered

5.6.4 Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.6.5 Teva Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.6.6 Teva Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.6.7 Teva Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.6.8 Teva Recent Developments

5.7 Mylan

5.7.1 Mylan Corporation Information

5.7.2 Mylan Description, Business Overview

5.7.3 Mylan Post herpetic Neuralgia Treatment Products Offered

5.7.4 Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.7.5 Mylan Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.7.6 Mylan Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.7.7 Mylan Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.7.8 Mylan Recent Developments

5.8 Hengrui Medicine

5.8.1 Hengrui Medicine Corporation Information

5.8.2 Hengrui Medicine Description, Business Overview

5.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Products Offered

5.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)

5.8.5 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Product in 2024

5.8.6 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024

5.8.7 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024

5.8.8 Hengrui Medicine Recent Developments

6 North America

6.1 North America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031

6.2 North America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)

6.3 North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)

6.4 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)

7.4 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)

8 Europe

8.1 Europe Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031

8.2 Europe Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)

8.3 Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)

8.4 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)

9 Latin America

9.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031

9.2 Latin America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)

9.3 Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)

9.4 Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)

10 Middle East and Africa

10.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)

10.4 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Post herpetic Neuralgia Treatment Supply Chain Analysis

11.2 Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers

11.3 Post herpetic Neuralgia Treatment Clients Analysis

11.4 Post herpetic Neuralgia Treatment Sales Channel and Sales Model Analysis

11.4.1 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Post herpetic Neuralgia Treatment Distributors

12 Post herpetic Neuralgia Treatment Market Dynamics

12.1 Post herpetic Neuralgia Treatment Industry Trends

12.2 Post herpetic Neuralgia Treatment Market Drivers

12.3 Post herpetic Neuralgia Treatment Market Challenges

12.4 Post herpetic Neuralgia Treatment Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

TEVA

Mylan NV

Hengrui Medicine

List of Tables

Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Post herpetic Neuralgia Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 9. Global Post herpetic Neuralgia Treatment Revenue Forecast by Distribution Channel (2026-2031) & (US$ Million)

Table 10. Post herpetic Neuralgia Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 11. Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Post herpetic Neuralgia Treatment Players by Revenue (US$ Million) in 2024

Table 13. Global Post herpetic Neuralgia Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2024)

Table 15. Global Post herpetic Neuralgia Treatment Companies Headquarters

Table 16. Date of International Companies Enter into Post herpetic Neuralgia Treatment Market

Table 17. Global Post herpetic Neuralgia Treatment Companies Product & Service

Table 18. Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans

Table 19. Pfizer Corporation Information

Table 20. Pfizer Description and Business Overview

Table 21. Pfizer Post herpetic Neuralgia Treatment Product

Table 22. Pfizer Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 24. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 25. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 26. Pfizer Recent Developments

Table 27. Arbor Pharma Corporation Information

Table 28. Arbor Pharma Description and Business Overview

Table 29. Arbor Pharma Post herpetic Neuralgia Treatment Product

Table 30. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 32. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 33. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 34. Arbor Pharma Recent Developments

Table 35. Assertio Therapeutics Corporation Information

Table 36. Assertio Therapeutics Description and Business Overview

Table 37. Assertio Therapeutics Post herpetic Neuralgia Treatment Product

Table 38. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 40. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 41. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 42. Assertio Therapeutics Recent Developments

Table 43. Endo Pharma Corporation Information

Table 44. Endo Pharma Description and Business Overview

Table 45. Endo Pharma Post herpetic Neuralgia Treatment Product

Table 46. Endo Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 48. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 49. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 50. Endo Pharma Recent Developments

Table 51. Teikoku Pharma Corporation Information

Table 52. Teikoku Pharma Description and Business Overview

Table 53. Teikoku Pharma Post herpetic Neuralgia Treatment Product

Table 54. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 56. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 57. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 58. Teikoku Pharma Recent Developments

Table 59. Teva Corporation Information

Table 60. Teva Description and Business Overview

Table 61. Teva Post herpetic Neuralgia Treatment Product

Table 62. Teva Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 64. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 65. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 66. Teva Recent Developments

Table 67. Mylan Corporation Information

Table 68. Mylan Description and Business Overview

Table 69. Mylan Post herpetic Neuralgia Treatment Product

Table 70. Mylan Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 72. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 73. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 74. Mylan Recent Developments

Table 75. Hengrui Medicine Corporation Information

Table 76. Hengrui Medicine Description and Business Overview

Table 77. Hengrui Medicine Post herpetic Neuralgia Treatment Product

Table 78. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024

Table 80. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024

Table 81. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024

Table 82. Hengrui Medicine Recent Developments

Table 83. North America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 84. North America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 85. North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 86. North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 87. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 88. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 89. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 90. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 91. Europe Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 92. Europe Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 93. Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 94. Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 95. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 96. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 97. Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 98. Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 99. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 100. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 101. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)

Table 102. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 103. Post herpetic Neuralgia Treatment Key Raw Materials, Industry Status and Trend

Table 104. Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers

Table 105. Post herpetic Neuralgia Treatment Clients Status and Trend

Table 106. Post herpetic Neuralgia Treatment Typical Clients

Table 107. Post herpetic Neuralgia Treatment Distributors

Table 108. Post herpetic Neuralgia Treatment Market Trends

Table 109. Post herpetic Neuralgia Treatment Market Drivers

Table 110. Post herpetic Neuralgia Treatment Market Challenges

Table 111. Post herpetic Neuralgia Treatment Market Restraints

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Post herpetic Neuralgia Treatment Product Picture

Figure 2. Global Post herpetic Neuralgia Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type in 2024 & 2031

Figure 4. Anticonvulsants Product Picture

Figure 5. Skin Patch Product Picture

Figure 6. Other Product Picture

Figure 7. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel in 2024 & 2031

Figure 9. Hospital Pharmacies

Figure 10. Online Pharmacies

Figure 11. Retail Pharmacies

Figure 12. Post herpetic Neuralgia Treatment Report Years Considered

Figure 13. Global Post herpetic Neuralgia Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Post herpetic Neuralgia Treatment Market Size (2020-2031) & (US$ Million)

Figure 15. Global Post herpetic Neuralgia Treatment Market Size Market Share by Region: 2024 Versus 2031

Figure 16. Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)

Figure 17. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Type (2020-2031)

Figure 18. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Distribution Channel (2020-2031)

Figure 19. Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031

Figure 20. Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031

Figure 21. Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031

Figure 22. Post herpetic Neuralgia Treatment Revenue Share by Company (2024)

Figure 23. Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Anticonvulsants Revenue Proportion by Company in 2024

Figure 25. Skin Patch Revenue Proportion by Company in 2024

Figure 26. Other Revenue Proportion by Company in 2024

Figure 27. North America Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)

Figure 28. North America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)

Figure 29. North America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)

Figure 30. Asia-Pacific Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)

Figure 31. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)

Figure 32. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)

Figure 33. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)

Figure 34. Europe Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)

Figure 35. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)

Figure 36. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)

Figure 37. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)

Figure 38. Latin America Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)

Figure 39. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)

Figure 40. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)

Figure 41. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)

Figure 42. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)

Figure 44. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)

Figure 45. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)

Figure 46. Post herpetic Neuralgia Treatment Supply Chain (Upstream and Downstream Market)

Figure 47. Global Production Market Share of Post herpetic Neuralgia Treatment Raw Materials by Region in 2024

Figure 48. Post herpetic Neuralgia Treatment Distribution Channels

Figure 49. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 50. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Online Sales VS Offline Sales

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Post Herpetic Neuralgia Drugs Market Research Report 2024

Global Post Herpetic Neuralgia Patches Market Research Report 2024

Global Trigeminal Neuralgia Treatment Market Insights Forecast to 2030

Global Trigeminal Neuralgia Treatment Medicine Market Insights Forecast to 2030

Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030

Herpes Simplex Virus Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Postoperative Pain Therapeutics Service Market Insights Forecast to 2030

Global Lidocaine Patches Market Research Report 2025

Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030

Global Herpes Infection Treatment Market Research Report 2025

Global Herpes Simplex Keratitis Drug Market Insights Forecast to 2030

Global Zika Virus Infection Treatment Market Research Report 2025

Global Postoperative Pain Therapeutics Market Insights Forecast to 2030

Global Herpes Zoste Drug Market Research Report 2025

Global Neuropathic Pain Management Market Insights Forecast to 2030

Global Herpes Zoster Treatment Market Insights Forecast to 2030

Global Post operative Pain Therapeutics Market Research Report 2025

Nerve Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Trigeminal Neuralgia Therapeutics Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions